Dataset Information

Computational Tools in the Discovery of FABP4 Ligands: A Statistical and Molecular Modeling Approach.

ABSTRACT: Small molecule inhibitors of adipocyte fatty-acid binding protein 4 (FABP4) have received interest following the recent publication of their pharmacologically beneficial effects. Recently, it was revealed that FABP4 is an attractive molecular target for the treatment of type 2 diabetes, other metabolic diseases, and some type of cancers. In past years, hundreds of effective FABP4 inhibitors have been synthesized and discovered, but, unfortunately, none have reached the clinical research phase. The field of computer-aided drug design seems to be promising and useful for the identification of FABP4 inhibitors; hence, different structure- and ligand-based computational approaches have been used for their identification. In this paper, we searched for new potentially active FABP4 ligands in the Marine Natural Products (MNP) database. We retrieved 14,492 compounds from this database and filtered through them with a statistical and computational filter. Seven compounds were suggested by our methodology to possess a potential inhibitory activity upon FABP4 in the range of 97-331 nM. ADMET property prediction was performed to validate the hypothesis of the interaction with the intended target and to assess the drug-likeness of these derivatives. From these analyses, three molecules that are excellent candidates for becoming new drugs were found.

SUBMITTER: Floresta G

PROVIDER: S-EPMC6891735 | biostudies-literature | 2019 Oct

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Computational Tools in the Discovery of FABP4 Ligands: A Statistical and Molecular Modeling Approach.

Floresta Giuseppe G Gentile Davide D Perrini Giancarlo G Patamia Vincenzo V Rescifina Antonio A

Marine drugs 20191031 11

Small molecule inhibitors of adipocyte fatty-acid binding protein 4 (FABP4) have received interest following the recent publication of their pharmacologically beneficial effects. Recently, it was revealed that FABP4 is an attractive molecular target for the treatment of type 2 diabetes, other metabolic diseases, and some type of cancers. In past years, hundreds of effective FABP4 inhibitors have been synthesized and discovered, but, unfortunately, none have reached the clinical research phase. T ...[more]

PMID: 31683588

Similar Datasets

Project description:Healthy aging is associated with deficits in performance on episodic memory tasks. Popular verbal theories of the mechanisms underlying this decrement have primarily focused on inferred changes in associative memory. However, performance on any task is the result of interactions between different neurocognitive mechanisms, such as perceptuomotor, memory, and decision-making processes. As a result, age-related differences in performance could arise from multiple processes, which could lead to incomplete or incorrect conclusions about the sources of aging effects. In addition, standard statistical comparisons of group-level summary statistics, such as mean accuracy, may not provide sufficient information to allow detailed mechanistic explanations of age-related change. We argue that these and other drawbacks of relying exclusively on verbal theories can hamper replicability, transparency, and scientific progress in aging research and psychological science more generally, and that computational modeling is a tool that can address many of these limitations. Computational models make mathematically transparent claims about how latent processes give rise to observed behavior and decompose an individual's performance into model parameters governing hypothesized mechanisms. In this work, we present a short memory task designed for and analyzed with mechanistic model-based approaches. We provide an example of a computational model and fit the model to data from young and older adults with hierarchical Bayesian techniques in order to (a) detect differences in latent cognitive processes between young and older adults (as well as individual participants), (b) quantitatively compare models to assess different processes that could underlie performance, and (c) simulate data to make predictions for future experiments based on model mechanisms. We argue that computational modeling is a powerful tool to examine age differences in latent processes, make theories more transparent, and facilitate discovery in cognitive aging research. (PsycInfo Database Record (c) 2022 APA, all rights reserved).

Project description:Cell population heterogeneity can affect cellular response and is a major factor in drug resistance. However, there are few techniques available to represent and explore how heterogeneity is linked to population response. Recent high-throughput genomic, proteomic, and cellomic approaches offer opportunities for profiling heterogeneity on several scales. We have recently examined heterogeneity in vascular endothelial growth factor receptor (VEGFR) membrane localization in endothelial cells. We and others processed the heterogeneous data through ensemble averaging and integrated the data into computational models of anti-angiogenic drug effects in breast cancer. Here we show that additional modeling insight can be gained when cellular heterogeneity is considered. We present comprehensive statistical and computational methods for analyzing cellomic data sets and integrating them into deterministic models. We present a novel method for optimizing the fit of statistical distributions to heterogeneous data sets to preserve important data and exclude outliers. We compare methods of representing heterogeneous data and show methodology can affect model predictions up to 3.9-fold. We find that VEGF levels, a target for tuning angiogenesis, are more sensitive to VEGFR1 cell surface levels than VEGFR2; updating VEGFR1 levels in the tumor model gave a 64% change in free VEGF levels in the blood compartment, whereas updating VEGFR2 levels gave a 17% change. Furthermore, we find that subpopulations of tumor cells and tumor endothelial cells (tEC) expressing high levels of VEGFR (>35,000 VEGFR/cell) negate anti-VEGF treatments. We show that lowering the VEGFR membrane insertion rate for these subpopulations recovers the anti-angiogenic effect of anti-VEGF treatment, revealing new treatment targets for specific tumor cell subpopulations. This novel method of characterizing heterogeneous distributions shows for the first time how different representations of the same data set lead to different predictions of drug efficacy.

Dataset Information

Computational Tools in the Discovery of FABP4 Ligands: A Statistical and Molecular Modeling Approach.

Publications

Computational Tools in the Discovery of FABP4 Ligands: A Statistical and Molecular Modeling Approach.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets